← FDA Drug Approvals (Drugs@FDA)

PACLITAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-04-10

Drug application

FDA Application #

ANDA209657

Application type

Abbreviated New Drug Application (Generic)

Brand name

PACLITAXEL

Generic name

PACLITAXEL PROTEIN-BOUND PARTICLES

Active ingredients

PACLITAXEL

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2025-04-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown